Clinical trial
Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism
NCT00246441 · Medical University of South Carolina, Other · Completed
Key facts
| NCT number | NCT00246441 |
|---|---|
| Title | Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism |
| Official title | Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism |
| Lead sponsor | Medical University of South Carolina, Other |
| Collaborators | National Institute on Alcohol Abuse and Alcoholism (NIAAA) NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Social Anxiety Disorder, Social Phobia, Alcohol Use Disorder, Alcohol Abuse, Alcohol Dependence |
| Intervention type | Drug |
| Interventions | Paroxetine, Placebo |
| Enrollment | 42 |
| Start date | Mar 1, 2002 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Oct 31, 2005 |
| Last update posted | Sep 27, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: